An Effective Approach for Obtaining Optimal Sampling Windows for Population Pharmacokinetic Experiments

By Ogungbenro Kayode  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 1, 2009-01 ,pp. : 174-189

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Designs for Two-Arm, Phase II Clinical Trial Design with Multiple Constraints

By Mayo Matthew  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 106-124

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients

By Waterhouse Timothy   Redmann Stefanie   Duffull Stephen   Eccleston John  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 3-4, 2005-08 ,pp. : 521-545

Springer Publishing Company

Access to resources Recommend Favorite

Simultaneous optimal experimental design for in vitro binding parameter estimation

By Ernest C.   Karlsson Mats   Hooker Andrew  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 5, 2013-10 ,pp. : 573-585

Springer Publishing Company

Access to resources Recommend Favorite

An example of optimal phase II design for exposure response modelling

By Maloney Alan   Schaddelee Marloes   Freijer Jan   Krauwinkel Walter   Gelderen Marcel   Jacqmin Philippe   Simonsson Ulrika  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 5, 2010-10 ,pp. : 475-491

Springer Publishing Company

Access to resources Recommend Favorite